Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Black Diamond Therapeutics, Inc. (BDTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
5 Jul 2023
Behbahani Ali
Director
Black Diamond Therapeutics, Inc.
(BDTX)
4,448,757
+28%
1,000,000
$5.00
$5,000,000.00
BUY
5 Jul 2023
RA CAPITAL MANAGEMENT, L.P.
Director
Black Diamond Therapeutics, Inc.
(BDTX)
3,213,828
+41%
935,850
$5.00
$4,679,250.00
BUY
30 Jun 2023
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
8,117,839
+14%
1,000,000
$5.00
$5,000,000.00
SELL
27 Jun 2023
Epstein David M.
SEE REMARKS, Director, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
671,423
-3%
25,000
$6.70
$167,500.00
BUY
27 Jun 2023
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
7,117,839
+32%
1,740,000
$5.49
$9,555,036.00
BUY
21 Dec 2022
Ni Fang
SEE REMARKS, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
125,389
+81%
56,363
$1.28
$72,365.55
BUY
31 Oct 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
5,377,839
+1%
99,801
$2.25
$224,911.52
BUY
27 Oct 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
5,278,038
+7%
364,652
$2.02
$736,186.00
BUY
21 Oct 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
4,913,386
+1%
87,850
$1.51
$132,750.14
BUY
19 Oct 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
4,825,536
+2%
131,423
$1.36
$179,120.05
BUY
29 Jun 2022
Ni Fang
SEE REMARKS, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
69,026
+56%
25,000
$2.44
$61,017.50
BUY
27 Apr 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
4,694,113
+9%
405,711
$2.61
$1,057,347.80
BUY
18 Apr 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
4,288,402
+7%
300,000
$3.27
$980,580.00
BUY
12 Apr 2022
BIOTECH GROWTH N V
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
3,988,402
+6%
252,556
$3.48
$879,817.25
SELL
12 May 2021
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
11,317
-26%
4,078
$27.42
$111,804.82
SELL
3 May 2021
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,200
-43%
2,500
$26.64
$66,602.25
SELL
12 Apr 2021
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
8,400
-32%
4,078
$25.00
$101,950.00
SELL
5 Apr 2021
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,200
-43%
2,500
$25.54
$63,847.50
SELL
12 Mar 2021
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
8,400
-32%
4,078
$26.36
$107,493.23
SELL
3 Mar 2021
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
4,084
-37%
2,500
$26.10
$65,261.84
SELL
12 Feb 2021
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
8,707
-31%
4,078
$27.23
$111,024.94
SELL
3 Feb 2021
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,200
-43%
2,500
$25.35
$63,375.00
SELL
12 Jan 2021
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
17,930
-39%
11,578
$34.03
$394,040.62
SELL
8 Jan 2021
Leggett Thomas
Chief Financial Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
3,000
$33.94
$101,819.99
SELL
4 Jan 2021
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,737
-40%
2,500
$31.41
$78,524.67
SELL
4 Jan 2021
Epstein David M.
See Remarks, Director, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
698,438
-1%
12,000
$31.13
$373,504.94
SELL
14 Dec 2020
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,000
-57%
4,078
$34.95
$142,522.44
SELL
8 Dec 2020
Leggett Thomas
Chief Financial Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
1,941
-60%
3,000
$33.78
$101,326.80
SELL
3 Dec 2020
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
2,500
$32.42
$81,055.25
SELL
1 Dec 2020
Epstein David M.
See Remarks, Director, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
704,000
-1%
12,000
$32.71
$392,573.75
SELL
27 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
874,299
-1%
10,393
$33.15
$344,512.75
SELL
27 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
874,299
-1%
10,393
$33.15
$344,512.75
SELL
19 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
968,954
-11%
130,017
$33.01
$4,291,861.00
SELL
19 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
968,954
-11%
130,017
$33.01
$4,291,861.00
SELL
17 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
984,117
-0%
4,730
$33.05
$156,349.16
SELL
17 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
984,117
-0%
4,730
$33.05
$156,349.16
SELL
13 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
984,669
-0%
4,700
$33.74
$158,586.75
SELL
13 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
984,669
-0%
4,700
$33.74
$158,586.75
SELL
12 Nov 2020
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
5,511
-42%
4,078
$33.99
$138,606.55
SELL
11 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
986,512
-1%
15,598
$34.15
$532,642.00
SELL
11 Nov 2020
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
5,000
$34.90
$174,500.00
SELL
11 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
986,512
-1%
15,598
$34.15
$532,642.00
SELL
10 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
988,227
-3%
39,583
$34.11
$1,350,353.80
SELL
10 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
988,227
-3%
39,583
$34.11
$1,350,353.80
SELL
9 Nov 2020
Leggett Thomas
Chief Financial Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
3,000
$32.96
$98,891.70
SELL
6 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
991,652
-0%
9,400
$33.08
$310,948.62
SELL
6 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
991,652
-0%
9,400
$33.08
$310,948.62
SELL
4 Nov 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
992,749
-1%
11,348
$33.14
$376,126.56
SELL
4 Nov 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
992,749
-1%
11,348
$33.14
$376,126.56
SELL
3 Nov 2020
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
2,500
$31.95
$79,873.00
SELL
2 Nov 2020
Epstein David M.
See Remarks, Director, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
712,006
-1%
12,000
$31.14
$373,656.40
SELL
26 Oct 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
994,073
-0%
8,903
$33.28
$296,293.20
SELL
26 Oct 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
994,073
-0%
8,903
$33.28
$296,293.20
SELL
15 Oct 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
995,111
-1%
15,746
$33.44
$526,528.90
SELL
15 Oct 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
995,111
-1%
15,746
$33.44
$526,528.90
SELL
13 Oct 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
996,948
-1%
17,240
$33.30
$574,015.40
SELL
13 Oct 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
996,948
-1%
17,240
$33.30
$574,015.40
SELL
12 Oct 2020
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,295
-55%
4,078
$32.70
$133,330.92
SELL
8 Oct 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
998,959
-2%
22,625
$33.50
$757,923.75
SELL
8 Oct 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
998,959
-2%
22,625
$33.50
$757,923.75
SELL
8 Oct 2020
Leggett Thomas
Chief Financial Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
3,000
$33.53
$100,575.90
SELL
6 Oct 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
1,041,206
-4%
45,926
$33.44
$1,535,732.20
SELL
6 Oct 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
1,041,206
-4%
45,926
$33.44
$1,535,732.20
SELL
5 Oct 2020
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
227
-91%
2,500
$31.28
$78,187.74
SELL
1 Oct 2020
Epstein David M.
See Remarks, Director, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
720,923
-1%
12,000
$30.33
$363,962.40
BUY
30 Sep 2020
INGRAM ROBERT ALEXANDER
Director
Black Diamond Therapeutics, Inc.
(BDTX)
5,000
+100%
5,000
$30.46
$152,285.00
SELL
14 Sep 2020
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
4,393
-48%
4,078
$31.04
$126,583.05
SELL
14 Sep 2020
Leggett Thomas
Chief Financial Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
0
-100%
3,000
$31.00
$93,000.00
SELL
3 Sep 2020
Roberts Christopher D.
Chief Scientific Officer, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
2,358
-51%
2,500
$29.59
$73,987.40
SELL
10 Aug 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
1,125,778
-1%
13,792
$33.06
$455,989.30
SELL
10 Aug 2020
Bolzon Bradley J PhD
Director, 10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
1,125,778
-1%
13,792
$33.06
$455,989.30
BUY
3 Feb 2020
Hatzis-Schoch Brent
See Remarks, Officer
Black Diamond Therapeutics, Inc.
(BDTX)
3,000
+100%
3,000
$19.00
$57,000.00
BUY
3 Feb 2020
Versant Venture Capital VI, L.P.
10% Owner
Black Diamond Therapeutics, Inc.
(BDTX)
2,209,592
+68%
894,736
$19.00
$16,999,984.00
BUY
3 Feb 2020
Flynn James E
10% Owner, Possible Member of 10% Group
Black Diamond Therapeutics, Inc.
(BDTX)
778,790
+105%
400,000
$19.00
$7,600,000.00
BUY
3 Feb 2020
Shah Rajeev M.
Director
Black Diamond Therapeutics, Inc.
(BDTX)
1,924,164
+108%
1,000,000
$19.00
$19,000,000.00
BUY
3 Feb 2020
Behbahani Ali
Director
Black Diamond Therapeutics, Inc.
(BDTX)
3,448,757
+30%
800,000
$19.00
$15,200,000.00
BUY
3 Feb 2020
Bolzon Bradley J PhD
Director
Black Diamond Therapeutics, Inc.
(BDTX)
2,209,592
+68%
894,736
$19.00
$16,999,984.00
Home